PFES Logo Patient & Family Education
Our Words.    Our Care.    Online.

Zevalin (yttrium-90 ibritumomab tiuxetan) for transplant patients  
Abstract:  This handout describes the medication Zevalin as it is given to transplant patients. It includes how it is given/taken, common side effects and possible drug-drug or drug-food interactions. Authored by Seattle Cancer Care Alliance, this information is made available to UWMC clinicians by agreement between SCCA and UWMC, as a service to the patients who visit both health care facilities.
Author: Seattle Cancer Care Alliance
Publisher/Date/Rev:  Seattle Cancer Care Alliance, 2012, April 1, 2012
UWMC Availability:  Seattle Cancer Care Alliance
General Topics:  Drug Therapy; Cancer
Specific Subject(s):  Side Effects; Self Care; Drug Therapy; Chemotherapy
Language(s):  English
Audience:  Caregiver; Patient
Format: Brochure
Reading Level: Technical
Cost: Unknown
Web Site Location:

Health Online Citation #3987

To Order Copies:
Please reference Citation number listed above when ordering copies of this document.

UWMC-authored: Print document from this Web site, or contact authoring department for master. For multiple copies, contact UWMC Copy Services, 206-598-4019.

Non-UWMC authored: For photocopy or information, contact PFES, 206-598-7498; or contact the department listed in the "UWMC Availability" field above.

The health education materials accessed through this site are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your doctor or other health care provider with any questions you may have about a medical condition.
If you think you have a medical emergency, call your doctor or 9-1-1 immediately.